CRNX - Crinetics Pharmaceuticals EPS misses by $0.03 November, 06 2020 08:34 AM Crinetics Pharmaceuticals Inc. Crinetics Pharmaceuticals (CRNX): Q3 GAAP EPS of -$0.56 misses by $0.03.Cash, cash equivalents and investments of $186.8M.Press Release For further details see: Crinetics Pharmaceuticals EPS misses by $0.03